Rucaparib Active Not Recruiting Phase 2 Trials for Fallopian Tube Cancer / Malignant Peritoneal Neoplasm / Cancer of the Ovary / Ovarian Epithelial Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01891344A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)